Budi Starch Sweetener Tbk vs Prodia Diagnostic Line Tbk — how do they compare? Budi Starch Sweetener Tbk trades at Rp220 (market cap 989.78B, 62K 24h volume), while Prodia Diagnostic Line Tbk trades at Rp264 (market cap 470.58B, 16.6M 24h volume). The key difference: Budi Starch Sweetener Tbk is far larger — about 2.1× Prodia Diagnostic Line Tbk's market cap, and Prodia Diagnostic Line Tbk is more actively traded (16.6M versus 62K). Which is the better fit depends on your goals.
| BUDI | PRDL | |
|---|---|---|
Market Cap | 989.78B | 470.58B |
Volume | 62K | 16.6M |
Lot | 620 | 165.96K |
Turnover | 13.63M | 4.37B |
Average Price | 219.86 | 263.54 |
Value | 13.63M | 4.37B |
Indicative Equilibrium Price | 224 | 272 |
Indicative Equilibrium Volume | 3 | 418 |
Trailing returns across standard periods
Latest headlines on both assets
PT Budi Starch & Sweetener Tbk (the Company) formerly Budi Acid Jaya (BAJ) was established based on Notarial Deed No. 15 dated January 15, 1979 of Henk Limanow, SH., public notary in Jakarta. PT Budi Starch & Sweetener Tbk is the world`s largest tapioca starch producer. BAJ is an integrated cassava based manufacturer : citric acid, modified tapioca starch and monosodium glutamate (MSG). It also produces sulphuric acid and poly propelene woven bag.
Read more on BUDI →PT Prodia Diagnostic Line Tbk (the Company) was established April 16, 2010 with the name of PT DiaLine Systems Indonesia based on Notarial Deed No. 22 of Rismalena Kasri, S.H. On April 25, 2011, PT DiaLine Systems Indonesia changed the Companys name to PT Prodia Diagnostic Line based on Notarial Deed No. 14 of Rismalena Kasri, S.H. The Company is in the form of a Limited Liability Company in 2010 and began commercial production in 2011. The production results are marketed locally. The parent and ultimate parent entity of the Company is PT Prodia Utama.
Read more on PRDL →